Nope [Two-Stage / GS Designs]

posted by nobody – 2017-11-14 09:11 (2728 d 08:08 ago) – Posting: # 17978
Views: 10,008

IANAL, but I think what San-Diego-man is proposing is to calculate BE-outcome (pass/fail) after stage 1 and compare it to BE-outcome after the (unnecessary) second stage for, let's say, 1 gazillion of studies and see if there is a meaningful difference.

Isn't this a special example of the more general "forced BE" theme in one-stage designs?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,666 registered users;
100 visitors (0 registered, 100 guests [including 8 identified bots]).
Forum time: 18:20 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5